Recombinant TRKA antibody
Quick Overview for Recombinant TRKA antibody (ABIN7828443)
Target
See all TRKA (NTRK1) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Recombinant Pan Trk Monoclonal Antibody
-
Purification
- Protein A purified
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- WB 1000-1:2000,IHC 1:50-1:100
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
Expiry Date
- 12 months
-
-
- TRKA (NTRK1) (Neurotrophic Tyrosine Kinase, Receptor, Type 1 (NTRK1))
-
Alternative Name
- Pan Trk
-
Background
- NTRK,Neurotrophic Tyrosine Kinase Receptor Type,NTRK2,GP145-TrkB,TRKB,trk-B,OBHD,BDNF/NT-3 Growth Factors Receptor,Neurotrophic Tyrosine Kinase Receptor Type 2,TrkB Tyrosine Kinase,Tropomyosin-Related Kinase B,TrkB receptor,The family of Trk receptor tyrosine kinases consists of TrkA, TrkB, and TrkC. While the sequence of these family members is highly conserved, they are activated by different neurotrophins: TrkA by NGF, TrkB by BDNF or NT4, and TrkC by NT3. Neurotrophin signaling through these receptors regulates a number of physiological processes, such as cell survival, proliferation, neural development, and axon and dendrite growth and patterning. In the adult nervous system, the Trk receptors regulate synaptic strength and plasticity. TrkA regulates proliferation and is important for development and maturation of the nervous system. Phosphorylation at Tyr490 is required for Shc association and activation of the Ras-MAP kinase cascade. Residues Tyr674/675 lie within the catalytic domain, and phosphorylation at these sites reflects TrkA kinase activity. Point mutations, deletions, and chromosomal rearrangements (chimeras) cause ligand-independent receptor dimerization and activation of TrkA. TrkA is activated in many malignancies including breast, ovarian, prostate, and thyroid carcinomas. Research studies suggest that expression of TrkA in neuroblastomas may be a good prognostic marker as TrkA signals growth arrest and differentiation of cells originating from the neural crest. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
Molecular Weight
-
Calculated MW: 92 kDa
Observed MW: 120-140 kDa The actual band is not consistent with the expectation.
-
UniProt
- Q16620
-
Pathways
- RTK Signaling, Neurotrophin Signaling Pathway, cAMP Metabolic Process
Target
-